Assistant Professor at David Geffen School of Medicine at UCLA.
Dr. Christopher Seet is a hematologist and oncologist subspecializing in the treatment of hematologic malignancies, including hematopoietic stem cell transplantation, cellular therapy, and clinical trials of novel therapeutics. Dr. Seet received his undergraduate degree in Biological Science at the University of Chicago; medical degree at the University of Sydney, Australia; and PhD in Cellular and Molecular Pathology at UCLA. Dr. Seet completed internship and residency in Internal Medicine at Loyola University Medical Center in Chicago, and Hematology/Oncology fellowship at UCLA. Dr. Seet has an active basic science and translational research program in developmental immunology and cellular immunotherapy. His research focuses on human T cell and dendritic cell tumor immunology, and the development of engineered stem cell-based approaches to cancer immunotherapy.
Dr. Seet is a Broad Stem Cell Research Center Clinical Fellow, recipient of a UCLA KL2 Translational Science Award, and a previous UCLA STAR program fellow. He is a member of the American Society of Hematology and American Society of Clinical Oncology.
Visit website: https://www.uclahealth.org/christopher-seet
See also: University of California, Los Angeles (UCLA) - Public land-grant research university
Christopher Seet News
Artificial Thymus to Create Cancer-Fighting Cells
UCLA - 10-Apr-2017
T-cells mature within this gland. People with some types of cancer are not getting the biologica...Read more...